GRAL
GRAIL Inc.

1,937
Mkt Cap
$3.8B
Volume
450,509.00
52W High
$118.84
52W Low
$20.44
PE Ratio
-8.40
GRAL Fundamentals
Price
$97.50
Prev Close
$95.89
Open
$96.67
50D MA
$97.84
Beta
2.44
Avg. Volume
836,550.20
EPS (Annual)
-$59.81
P/B
1.57
Rev/Employee
$125,595.00
$90.33
Loading...
Loading...
News
all
press releases
GRAIL to Announce Fourth Quarter and Full Year 2025 Financial Results
GRAIL to Announce Fourth Quarter and Full Year 2025 Financial Results GRAIL to Announce Fourth Quarter and Full Year 2025 Financial Results PR Newswire MENLO PARK, Calif., Feb. 16, 2026 MENLO PARK...
PR Newswire·10h ago
News Placeholder
More News
News Placeholder
GRAIL (GRAL) Projected to Post Earnings on Thursday
GRAIL (NASDAQ:GRAL) will be releasing its Q4 2025 earnings before the market opens on Thursday, February 19. (View Earnings Report at...
MarketBeat·5d ago
News Placeholder
Moloney Securities Asset Management LLC Has $959,000 Stock Holdings in GRAIL, Inc. $GRAL
Moloney Securities Asset Management LLC lowered its stake in GRAIL, Inc. (NASDAQ:GRAL - Free Report) by 59.6% during the third quarter, according to the company in its most recent filing with the...
MarketBeat·9d ago
News Placeholder
GRAIL, Inc. $GRAL Shares Purchased by Allianz Asset Management GmbH
Allianz Asset Management GmbH lifted its stake in shares of GRAIL, Inc. (NASDAQ:GRAL - Free Report) by 145.9% during the third quarter, according to its most recent disclosure with the Securities...
MarketBeat·9d ago
News Placeholder
GRAIL Submits FDA PMA for Galleri Multi-Cancer Early Detection Test
GRAL submits final FDA PMA module for the Galleri MCED test, reaching a milestone in broader cancer screening and potential public health impacts.
Zacks·17d ago
News Placeholder
Trifecta Capital Advisors LLC Purchases 10,250 Shares of GRAIL, Inc. $GRAL
Trifecta Capital Advisors LLC lifted its position in shares of GRAIL, Inc. (NASDAQ:GRAL - Free Report) by 89.9% during the third quarter, according to its most recent disclosure with the Securities...
MarketBeat·17d ago
News Placeholder
GRAIL Submits FDA Premarket Approval Application for the Galleri Multi-Cancer Early Detection Test
GRAIL Submits FDA Premarket Approval Application for the Galleri Multi-Cancer Early Detection Test GRAIL Submits FDA Premarket Approval Application for the Galleri Multi-Cancer Early Detection Test...
PR Newswire·18d ago
News Placeholder
GRAIL (NASDAQ:GRAL) Trading Down 7.7% - Here's Why
GRAIL (NASDAQ:GRAL) Trading Down 7.7% - Here's What Happened...
MarketBeat·24d ago
News Placeholder
GRAIL (NASDAQ:GRAL) Reaches New 12-Month High - What's Next?
GRAIL (NASDAQ:GRAL) Reaches New 1-Year High - Here's What Happened...
MarketBeat·25d ago
News Placeholder
GRAIL (NASDAQ:GRAL) Trading Up 8.4% - Still a Buy?
GRAIL (NASDAQ:GRAL) Stock Price Up 8.4% - Here's Why...
MarketBeat·27d ago
<
1
2
...
>

Latest GRAL News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.